☰

Patrick G. Holder, Ph.D. - Publications

Affiliations: 
2008 University of California, Berkeley, Berkeley, CA, United States 
Area:
Organic, Bioorganic, and Materials Chemistry
Tree Info Similar researchers PubMed Report error

10/24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Shatz-Binder W, Azumaya CM, Leonard B, Vuong I, Sudhamsu J, Rohou A, Liu P, Sandoval W, Bol K, Izadi S, Holder PG, Blanchette C, Perozzo R, Kelley RF, Kalia Y. Adapting Ferritin, a Naturally Occurring Protein Cage, to Modulate Intrinsic Agonism of OX40. Bioconjugate Chemistry. PMID 38592684 DOI: 10.1021/acs.bioconjchem.4c00020  0.32
2020 Yamazoe S, Hogan J, West S, Deng X, Kotapati S, Shao X, Holder P, Lamba V, Huber M, Qiang C, Gangwar S, Rao C, Dollinger G, Rajpal A, Strop P. High-Throughput Platform to Identify Antibody Conjugation Sites from Antibody-Drug Conjugate Libraries. Bioconjugate Chemistry. PMID 32178516 DOI: 10.1021/Acs.Bioconjchem.0C00146  0.467
2016 York D, Baker J, Holder PG, Jones LC, Drake PM, Barfield RM, Bleck GT, Rabuka D. Generating aldehyde-tagged antibodies with high titers and high formylglycine yields by supplementing culture media with copper(II). Bmc Biotechnology. 16: 23. PMID 26911368 DOI: 10.1186/S12896-016-0254-0  0.454
2015 Kudirka R, Barfield RM, McFarland J, Albers AE, de Hart GW, Drake PM, Holder PG, Banas S, Jones LC, Garofalo AW, Rabuka D. Generating site-specifically modified proteins via a versatile and stable nucleophilic carbon ligation. Chemistry & Biology. 22: 293-8. PMID 25619935 DOI: 10.1016/J.Chembiol.2014.11.019  0.657
2014 Drake PM, Albers AE, Baker J, Banas S, Barfield RM, Bhat AS, de Hart GW, Garofalo AW, Holder P, Jones LC, Kudirka R, McFarland J, Zmolek W, Rabuka D. Aldehyde tag coupled with HIPS chemistry enables the production of ADCs conjugated site-specifically to different antibody regions with distinct in vivo efficacy and PK outcomes. Bioconjugate Chemistry. 25: 1331-41. PMID 24924618 DOI: 10.1021/Bc500189Z  0.652
2012 Pizano AA, Lutterman DA, Holder PG, Teets TS, Stubbe J, Nocera DG. Photo-ribonucleotide reductase β2 by selective cysteine labeling with a radical phototrigger. Proceedings of the National Academy of Sciences of the United States of America. 109: 39-43. PMID 22171005 DOI: 10.1073/Pnas.1115778108  0.324
2011 Holder PG, Nocera DG, Francis MB, Stubbe J. Guiding and measuring electron transfers in biomolecules: Lessons for photovoltaics, materials, and medicine Acs National Meeting Book of Abstracts.  0.433
2010 Holder PG, Finley DT, Stephanopoulos N, Walton R, Clark DS, Francis MB. Dramatic thermal stability of virus-polymer conjugates in hydrophobic solvents. Langmuir : the Acs Journal of Surfaces and Colloids. 26: 17383-8. PMID 20964388 DOI: 10.1021/La1039305  0.668
2007 Kovacs EW, Hooker JM, Romanini DW, Holder PG, Berry KE, Francis MB. Dual-surface-modified bacteriophage MS2 as an ideal scaffold for a viral capsid-based drug delivery system. Bioconjugate Chemistry. 18: 1140-7. PMID 17602681 DOI: 10.1021/Bc070006E  0.466
2007 Holder PG, Francis MB. Integration of a self-assembling protein scaffold with water-soluble single-walled carbon nanotubes Angewandte Chemie - International Edition. 46: 4370-4373. PMID 17458849 DOI: 10.1002/Anie.200700333  0.502
Low-probability matches (unlikely to be authored by this person)
2015 Holder PG, Jones LC, Drake PM, Barfield RM, Bañas S, de Hart GW, Baker J, Rabuka D. Reconstitution of Formylglycine-generating Enzyme with Copper(II) for Aldehyde Tag Conversion. The Journal of Biological Chemistry. 290: 15730-45. PMID 25931126 DOI: 10.1074/Jbc.M115.652669  0.283
2021 Sivaprakasam P, McDonald I, Iwuagwu C, Chowdari NS, Peese KM, Langley DR, Cheng H, Luzung MR, Schmidt MA, Zheng B, Tan Y, Cho P, Rakshit S, Lakshminarasimhan T, Guturi S, ... ... Holder P, et al. DNA-Model-Based Design and Execution of Some Fused Benzodiazepine Hybrid Payloads for Antibody-Drug Conjugate Modality. Acs Medicinal Chemistry Letters. 12: 404-412. PMID 33738068 DOI: 10.1021/acsmedchemlett.0c00578  0.278
2015 Song DY, Pizano AA, Holder PG, Stubbe J, Nocera DG. Direct Interfacial Y731 Oxidation in α2 by a Photoβ2 Subunit of E. coli Class Ia Ribonucleotide Reductase. Chemical Science (Royal Society of Chemistry : 2010). 6: 4519-4524. PMID 26504513 DOI: 10.1039/C5Sc01125F  0.264
2013 Pizano AA, Olshansky L, Holder PG, Stubbe J, Nocera DG. Modulation of Y356 photooxidation in E. coli class Ia ribonucleotide reductase by Y731 across the α2:β2 interface. Journal of the American Chemical Society. 135: 13250-3. PMID 23927429 DOI: 10.1021/Ja405498E  0.264
2012 Holder PG, Pizano AA, Anderson BL, Stubbe J, Nocera DG. Deciphering radical transport in the large subunit of class I ribonucleotide reductase. Journal of the American Chemical Society. 134: 1172-80. PMID 22121977 DOI: 10.1021/Ja209016J  0.253
2022 Kelley RF, Tesar DB, Wang Y, Agard NJ, Holder PG, Chan J, Comps-Agrar L, Horvath J, Horvath JD, Crowell SR. Generation of a Porcine Antibody Fab Fragment Using Protein Engineering to Facilitate the Evaluation of Ocular Sustained Delivery Technology. Molecular Pharmaceutics. PMID 35393854 DOI: 10.1021/acs.molpharmaceut.2c00048  0.213
2022 Camperi J, Console G, Zheng L, Stephens N, Montti M, Roper B, Zheng M, Moshref M, Dagdas Y, Holder P, Stella C. Comprehensive UHPLC- and CE-based methods for engineered Cas9 characterization. Talanta. 252: 123780. PMID 35988299 DOI: 10.1016/j.talanta.2022.123780  0.198
2015 Barfield RM, Holder PG, Rabuka D. Designing optimised, site-specific ADCs Manufacturing Chemist. 86: 38-41.  0.152
2023 Chu PY, Wang H, Ross E, Stephens N, Zhang HM, Andersen N, Chan W, Shivva V, Crowell SR, Spiess C, Holder PG, Agard NJ, Ji C, Chen J, Sreedhara A, et al. Translatability of Stress for Predicting Deamidation and Oxidation Biotransformation on Biotherapeutics. Analytical Chemistry. 95: 17957-17961. PMID 38084380 DOI: 10.1021/acs.analchem.3c02133  0.146
2024 Shehata HM, Dogra P, Gierke S, Holder P, Sanjabi S. Efbalropendekin Alfa enhances human natural killer cell cytotoxicity against tumor cell lines . Frontiers in Immunology. 15: 1341804. PMID 38515757 DOI: 10.3389/fimmu.2024.1341804  0.12
2022 Holder PG, Lim SA, Huang CS, Sharma P, Dagdas Y, Bulutoglu B, Sockolosky JT. Engineering interferons and interleukins for cancer immunotherapy. Advanced Drug Delivery Reviews. 114112. PMID 35085624 DOI: 10.1016/j.addr.2022.114112  0.108
2023 Lu D, Yadav R, Holder P, Chiang E, Sanjabi S, Poon V, Bernett M, Varma R, Liu K, Leung I, Bogaert L, Desjarlais J, Shivva V, Hosseini I, Ramanujan S. Complex PK-PD of an engineered IL-15/IL-15Rα-Fc fusion protein in cynomolgus monkeys: QSP modeling of lymphocyte dynamics. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 106450. PMID 37084985 DOI: 10.1016/j.ejps.2023.106450  0.103
2015 Song DY, Pizano AA, Holder PG, Stubbe J, Nocera DG. Direct interfacial Y731 oxidation in α2 by a photoβ2 subunit of E. coli class Ia ribonucleotide reductase Chemical Science. 6: 4519-4524. DOI: 10.1039/c5sc01125f  0.062
2017 Eames KC, Holder P, Zambrano E. Solving the kidney shortage via the creation of kidney donation co-operatives. Journal of Health Economics. 54: 91-97. PMID 28482215 DOI: 10.1016/j.jhealeco.2017.04.001  0.024
Hide low-probability matches.